| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |